Paul P et al. |
Capillary electrophoresis with capacitively coupled contactless conductivity detection method development and validation for the determination of azithromycin, clarithromycin, and clindamycin. |
2017 |
J Sep Sci |
pmid:28683179
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
Malfertheiner P et al. |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
2017 |
Gut |
pmid:27707777
|
Morimoto K et al. |
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. |
2017 |
Ann Am Thorac Soc |
pmid:27788025
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Itskoviz D et al. |
Smoking increases the likelihood of Helicobacter pylori treatment failure. |
2017 |
Dig Liver Dis |
pmid:28427781
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Wong AYS et al. |
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis. |
2017 |
Drug Saf |
pmid:28397186
|
Aziz DB et al. |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28396540
|
Costa S et al. |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28877088
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Santos RP et al. |
induced rash and mucositis: a recently described entity. |
2017 |
BMJ Case Rep |
pmid:28830900
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Kwon S et al. |
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Eradication]. |
2017 |
Korean J Gastroenterol |
pmid:28830132
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Fremlin GA et al. |
Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp. |
2017 |
Clin. Exp. Dermatol. |
pmid:28691163
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Tan B et al. |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. |
2017 |
PLoS ONE |
pmid:28407007
|
Freyne B and Curtis N |
Mycobacterium gordonae Skin Infection in an Immunocompetent Child. |
2017 |
Pediatr. Infect. Dis. J. |
pmid:28403059
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Sasaoka Y et al. |
Neonatal apnea with Chlamydia pneumoniae infection. |
2017 |
Pediatr Int |
pmid:28102626
|
Lapa GB et al. |
Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin. |
2017 |
J Enzyme Inhib Med Chem |
pmid:28097898
|
Chen PY et al. |
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074519
|
Zamani M et al. |
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28074507
|
Zycinska K et al. |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. |
2016 |
Adv. Exp. Med. Biol. |
pmid:27620311
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Hirata Y et al. |
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen. |
2016 |
Int. J. Infect. Dis. |
pmid:27590563
|
Liou JM et al. |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. |
2016 |
Lancet |
pmid:27769562
|
Shichijo S et al. |
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice. |
2016 |
J Dig Dis |
pmid:27534444
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Lotfipour F et al. |
Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori. |
2016 |
Drug Res (Stuttg) |
pmid:25919643
|
Okano Y et al. |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report. |
2016 |
BMC Pulm Med |
pmid:27287608
|
Akram FE et al. |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). |
2016 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:27530257
|
Root AA et al. |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. |
2016 |
Br J Clin Pharmacol |
pmid:27090996
|
Kazama I et al. |
Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells. |
2016 |
Chemotherapy |
pmid:27088971
|
Huynh VA et al. |
[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]. |
2016 |
Ann Dermatol Venereol |
pmid:27080820
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Chua CS et al. |
The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial. |
2016 |
Int J Food Sci Nutr |
pmid:26883189
|
Meng X et al. |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. |
2016 |
Zhonghua Yi Xue Za Zhi |
pmid:26879786
|
Çağan-Appak Y et al. |
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children. |
2016 |
Turk. J. Pediatr. |
pmid:28276208
|
Thung I et al. |
Review article: the global emergence of Helicobacter pylori antibiotic resistance. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26694080
|
Lee J et al. |
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26373262
|
Tsujimae M et al. |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. |
2016 |
Digestion |
pmid:28030862
|